In Situ Shortening of CAG Repeat Length within the Androgen Receptor Gene in Prostatic Cancer and Its Possible Precursors

Prostate

Volumn 58, Issue 3, 2004, Pages 283-290

  Tsujimoto, Yuichi ^a   Takakuwa, Tetsuya ^a   Takayama, Hitoshi ^a   Nishimura, Kazuo ^a   Okuyama, Akihiko ^a   Aozasa, Katsuyuki ^a   Nonomura, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Androgen receptor; Bat 25; Bat 26; CAG repeat; GGC repeat; High grade prostatic intraepithelial neoplasia; Laser capture microdissection; Postatrophic hyperplasia; Prostatic cancer

Indexed keywords

ANDROGEN RECEPTOR; POLYGLUTAMINE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER RISK; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA EXTRACTION; GENE; GENE SEQUENCE; GENETIC TRANSCRIPTION; HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MALE; NUCLEOTIDE REPEAT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATE TUMOR;

AGED; GENE FREQUENCY; GLUTAMINE; HUMANS; LASERS; MALE; MICRODISSECTION; MICROSATELLITE REPEATS; MIDDLE AGED; PEPTIDES; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEATS;

EID: 0842306313     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10333     Document Type: Article

References (36)

1. Trapman J, Brinkmann AO. The androgen receptor in prostate cancer. Pathol Res Pract 1996;192:752-760.
2. Chang CS, Kokontis J, Liao ST. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 1988;85:7211-7215.
3. McPhaul MJ. Molecular defects of the androgen receptor. J Steroid Biochem Mol Biol 1999;69:315-322.
4. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995;55:1937-1940.
5. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181-3186.
6. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH, Kantoff PW. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997;94:3320-3323.
7. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997;89:166-170.
8. Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: A population-based case-control study in China. Cancer Res 2000;60:5111-5116.
9. Buchanan G, Irvine RA, Coetzee GA, Tilley WD. Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Rev 2001;20:207-223.
10. Giovannucci E. Is the androgen receptor CAG repeat length significant for prostate cancer? Cancer Epidemiol Biomarkers Prev 2002;11:985-986.
11. Buchanan G, Greenberg NM, Scher HI, Harris JM, Marshall VR, Tilley WD. Collocation of androgen receptor gene mutations in prostate cancer. Clin Cancer Res 2001;7:1273-1281.
12. Beilin J, Ball EM, Favaloro JM, Zajac JD. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: Specificity in prostate and non-prostate cell lines. J Mol Endocrinol 2000;25:85-96.
13. Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, Coetzee GA. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet 2000;9:267-274.
14. Gao T, Marcelli M, McPhaul MJ. Transcriptional activation and transient expression of the human androgen receptor. J Steroid Biochem Mol Biol 1996;59:9-20.
15. Schoenberg MP, Hakimi JM, Wang S, Bova GS, Epstein JI, Fischbeck KH, Isaacs WB, Walsh PC, Barrack ER. Microsatellite mutation (CAG24→18) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun 1994;198:74-80.
16. Terrell RB, Wille AH, Cheville JC, Nystuen AM, Cohen MB, Sheffield VC. Microsatellite instability in adenocarcinoma of the prostate. Am J Pathol 1995;147:799-805.
17. Uchida T, Wada C, Wang C, Ishida H, Egawa S, Yokoyama E, Ohtani H, Koshiba K. Microsatellite instability in prostate cancer. Oncogene 1995;10:1019-1022.
18. Egawa S, Uchida T, Suyama K, Wang C, Ohori M, Irie S, Iwamura M, Koshiba K. Genomic instability of microsatellite repeats in prostate cancer: Relationship to clinicopathological variables. Cancer Res 1995;55:2418-2421.
19. Watanabe M, Imai H, Shiraishi T, Shimazaki J, Kotake T, Yatani R. Microsatellite instability in human prostate cancer. Br J Cancer 1995;72:562-564.
20. Wallen MJ, Linja M, Kaartinen K, Schleutker J, Visakorpi T. Androgen receptor gene mutations in hormone-refractory prostate cancer. J Pathol 1999;189:559-563.
21. Wille AH, Terrell RB, Cheville JC, Sheffield VC, Cohen MB. Focal microsatellite mutations in relatives with prostatic adenocarcinoma. Anticancer Res 1996;16:3883-3886.
22. Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G, Hamelin R. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997;57:300-303.
23. Zhou XP, Hoang JM, Cottu P, Thomas G, Hamelin R. Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors. Oncogene 1997;15:1713-1718.
24. Zhou XP, Hoang JM, Li YJ, Seruca R, Carneiro F, Sobrinho-Simoes M, Lothe RA, Gleeson CM, Russell SE, Muzeau F, Flejou JF, Hoang-Xuan K, Lidereau R, Thomas G, Hamelin R. Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer 1998;21:101-107.
25. Bostwick DG. High grade prostatic intraepithelial neoplasia. The most likely precursor of prostate cancer. Cancer 1995;75:1823-1836.
26. Tsujimoto Y, Takayama H, Nonomura N, Okuyama A, Aozasa K. Postatrophic hyperplasia of the prostate in Japan-histologic and immunohistochemical features and p53 gene mutation analysis. Prostate 2002;52:279-287.
27. Bostwick DG, Myers RP, Oesterling JE. Staging of prostate cancer. Semin Surg Oncol 1994;10:60-72.
28. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA. Laser capture microdissection. Science 1996;274:998-1001.
29. Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S, Liotta LA. Laser capture microdissection: Molecular analysis of tissue. Science 1997;278:1481-1483.
30. Takakuwa T, Hongyo T, Syaifudin M, Kanno H, Matsuzuka F, Narabayashi I, Nomura T, Aozasa K. Microsatellite instability and k-ras, p53 mutations in thyroid lymphoma. Jpn J Cancer Res 2000;91:280-286.
31. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-819.
32. Sartor O, Zheng Q, Eastham JA. Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer. Urology 1999;53:378-380.
33. Hardy DO, Scher HI, Bogenreider T, Sabbatini P, Zhang ZF, Nanus DM, Catterall JF. Androgen receptor CAG repeat lengths in prostate cancer: Correlation with age of onset. J Clin Endocrinol Metab 1996;81:4400-4405.
34. Hakimi JM, Schoenberg MP, Rondinelli RH, Piantadosi S, Barrack ER. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res 1997;3:1599-1608.
35. Nam RK, Elhaji Y, Krahn MD, Hakimi J, Ho M, Chu W, Sweet J, Trachtenberg J, Jewett MA, Narod SA. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression. J Urol 2000;164:567-572.
36. Suzuki H, Akakura K, Komiya A, Ueda T, Imamoto T, Furuya Y, Ichikawa T, Watanabe M, Shiraishi T, Ito H. CAG polymorphic repeat lengths in androgen receptor gene among Japanese prostate cancer patients: Potential predictor of prognosis after endocrine therapy. Prostate 2002;51:219-224.